The Merck vaccine will continue to be provided to all people at high risk of Ebola infection including those who have been in contact with a person confirmed to have Ebola. Keep Reading
During the past 21 days (from 28 August through 17 September 2019), a total of 145 confirmed cases were reported from 14 health zones. Keep Reading
Alex Azar, speaking in Uganda, told reporters that he and others are “very concerned” and urged Tanzania’s government to share laboratory results. Keep Reading
WHO calls for the full force of all partners to respond and increase their presence in the field to stop Ebola and to address humanitarian crisis. Keep Reading
BARDA also will continue to work with Merck on advanced development of V920, also known as rVSV-ZEBOV, toward obtaining FDA licensure. Keep Reading
Among all patients who took the drugs, those treated with REGN-EB3 had a mortality rate of 29%, while those who got mAb-114 had a mortality rate of 34%. Keep Reading
Despite the continuing challenges, DRC and international partners including the U.S. government continue to mount a robust response. Keep Reading
The admission comes a week after WHO declared the Ebola outbreak in the DR Congo a "public health emergency of international concern." Keep Reading
The tears came last summer as the Christian physician visited with Dottie Schulz, a missionary care volunteer with Texas-based Mission Resource Network. Keep Reading
The first case has been confirmed in Goma, a city of almost two million people on the border with Rwanda and the gateway to the rest of DRC and the world. Keep Reading
